31 – 40 of 115
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Thromboembolic Disease in Patients With Cancer and COVID-19 : Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art
(
- Contribution to journal › Scientific review
-
Mark
Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients
(
- Contribution to journal › Article
-
Mark
Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp)
(
- Contribution to journal › Article
-
Mark
Molecular and Serologic Diagnostic Technologies for SARS-CoV-2
2022) In arXiv.org(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19
(
- Contribution to journal › Scientific review
-
Mark
Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation
(
- Contribution to journal › Letter
-
Mark
Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022
(
- Contribution to journal › Letter
-
Mark
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
(
- Contribution to journal › Letter
-
Mark
Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants
(
- Contribution to journal › Article
-
Mark
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study
(
- Contribution to journal › Article